Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
4
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
4
Past 30 days
0
Past 7 days
0
Today
0
User Comments
General
Stock
2021-06-06 10:59 | Report Abuse
The Government of China had recently granted the "Emergency Use Authorisation" (EUA) for the Covid-19 vaccine developed by YTBH's strategic partner, Shenzhen Kangtai Biological Products Co., Ltd. (“SZKT”)
SZKT has also commenced its vaccination programme in China, with its first batch of vaccination programme of more than 500,000 doses, on 1st June 2021. To date, SZKT's vaccines have been used on millions of China citizen.
With the EUA granted in China, this will pave the way for Malaysia and other countries to start using SZKT vaccines. As soon as some interim results can be gathered within 2 months after the phase 3 trial commenced, accelerated data can be obtained to substantiate the application for EUA in Malaysia & roll out for use thereafter.
Coming back to Yong Tai , the Phase III clinical trial involves 3,000 participants and could last several months or years, as Health director-general Tan Sri Dr Noor Hisham Abdullah mentioned. Prior to COVID-19 pandemic, a vaccine for infectious disease has never been produced in less than several years.
However, there has been an escalation in the approval of vaccines for emergency usage during this pandemic because no country can wait that long.
For example, Pfizer-BioNTech COVID-19 vaccine’s phase III clinical trial began on 27 July 2020 and received approval for emergency usage in November last year.
It will be interesting to see if SZKT's vaccine being granted an approval for emergency usage given the urgent needs for supply of vaccines as well as the earlier emergency usage approval granted by the Chinese government in May.
Stock
2021-06-05 21:10 | Report Abuse
https://kpkesihatan.com/2021/06/05/kenyataan-akhbar-kpk-5-jun-2021-kajian-klinikal-produk-sars-cov-2-vaccine-vero-cells-inactivated-keluaran-shenzhen-kangtai-biological-products-co-ltd-china/
The 15-19 months are full cycle for phase 3. It's normal for such a trial test.
But bear in mind this is an extraordinary situation with this pandemic. After 2 months into the trial, with the accelerated data already can bring in bulk vaccines
hwgb
2021-07-29 21:37 | Report Abuse
news